Integrated Biopharma Inc (INBP): EPS (Diluted)
-$0.09
Year ended 2026-06-30
| Period ended | EPS (Diluted) | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | -$0.09 | n/m | 2026-09-25, From 2025-07-01 |
| 2025-06-30 | $0.03 | n/a | 2026-09-25, From 2024-07-01 |
| 2024-06-30 | $0.00 | n/a | 2025-09-23, From 2023-07-01 |
| 2023-06-30 | $0.00 | -100.0% | 2024-09-20, From 2022-07-01 |
| 2022-06-30 | $0.12 | -52.0% | 2023-09-15, From 2021-07-01 |
| 2021-06-30 | $0.25 | +92.3% | 2022-09-13, From 2020-07-01 |
| 2020-06-30 | $0.13 | +116.7% | 2021-09-02, From 2019-07-01 |
| 2019-06-30 | $0.06 | +200.0% | 2020-09-23, From 2018-07-01 |
| 2018-06-30 | $0.02 | -80.0% | 2019-08-29, From 2017-07-01 |
| 2017-06-30 | $0.10 | +100.0% | 2018-09-12, From 2016-07-01 |
| 2016-06-30 | $0.05 | +150.0% | 2017-09-01, From 2015-07-01 |
| 2015-06-30 | $0.02 | +100.0% | 2016-09-02, From 2014-07-01 |
| 2014-06-30 | $0.01 | n/a | 2015-09-04, From 2013-07-01 |
| 2013-06-30 | $0.00 | n/m | 2014-09-08, From 2012-07-01 |
| 2012-06-30 | -$0.13 | n/a | 2013-09-30, From 2011-07-01 |
EPS (Diluted) at similar companies
| Company | Year ended | EPS (Diluted) | Change YoY |
|---|---|---|---|
| Integrated Biopharma Inc (INBP) | 2026-06-30 | -$0.09 | n/m |
| Xilio Therapeutics, Inc. (XLO) | 2025-12-31 | -$4.19 | n/m |
| Cumberland Pharmaceuticals Inc (CPIX) | 2025-12-31 | -$0.19 | n/m |
| Aquestive Therapeutics, Inc. (AQST) | 2025-12-31 | -$0.78 | n/m |
| Wave Life Sciences, Inc. (WVE) | 2025-12-31 | -$1.21 | n/m |
| Septerna, Inc. (SEPN) | 2025-12-31 | -$1.10 | n/m |
| Protagonist Therapeutics, Inc (PTGX) | 2025-12-31 | -$2.05 | n/m |
| Biofrontera Inc. (BFRI) | 2025-12-31 | -$1.04 | n/m |
| Gossamer Bio, Inc. (GOSS) | 2025-12-31 | -$0.75 | n/m |
Compare INBP, XLO, CPIX, AQST side by side · Screen every company in Pharmaceutical Preparations ↗